Similar articles

Abstract: Basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC), as certain forms of non-melanoma skin cancer (NMSC) or keratinocyte carcinoma, are the most common forms of malignant neoplasms worldwide (Sharp et al., 2024). BCC and cSCC have been identified as two major components of NMSC, comprising one-third of all malignancies (Burton et al., 2016). Generally speaking, patients with NMSC tend to have relatively favorable survival outcomes, while different histopathological subtypes of NMSC exhibit distinct biological behaviors (St?tescu et al., 2023). Keratinocyte carcinoma, although not considered as deadly as melanoma, tends to metastasize if left untreated (Civantos et al., 2023; Nanz et al., 2024). cSCC can evolve locally, then aggressively metastasize, invade, and even lead to fatal consequences in a subset of patients (Winge et al., 2023). A solid, pigmented, smooth plaque or a hyperkeratotic papule with or without central ulceration and hemorrhage appears to be characteristic of cSCC (Thompson et al., 2016; Zhou et al., 2023). Of note, a rare type of intraepidermal cSCC in situ often appears as a velvety, demarcated, slightly raised erythematous plaque on the genitalia of men (Yamaguchi et al., 2016). Accounting for approximately 16.0% of scalp tumors and with a rising incidence, cSCC is now the second most common NMSC in humans (Verdaguer-Faja et al., 2024). According to the latest statistics, up to 2%–5% of cSCCs in situ may gradually progress into invasive cSCCs in the final step (Rentroia-Pacheco et al., 2023). Several risk factors for the carcinogenesis and development of cSCC have been identified, including age, accumulative exposure to ultraviolet light radiation A and B, human papillomavirus infection, arsenic ingestion, chronic scarring, xeroderma pigmentosa, a relevant history of ionizing radiation, androgenetic alopecia in males, and immunosuppression therapy (Martinez and Otley, 2001; Welsch et al., 2012; Mortaja and Demehri, 2023).

原位5-氨基酮戊酸光动力疗法成功治愈1例53岁的老年原位皮肤鳞状细胞癌女性患者

[1]AhmadyS, NelemansPJ, Kelleners-SmeetsNWJ, et al., 2024. Surgical excision versus topical 5% 5-fluorouracil and photodynamic therapy in treatment of Bowen’s disease: a multicenter randomized controlled trial. J Am Acad Dermatol, 90(1):58-65.

[2]AlamM, ArmstrongA, BaumC, et al., 2018. Guidelines of care for the management of cutaneous squamous cell carcinoma. J Am Acad Dermatol, 78(3):560-578.

[3]AlamM, RatnerD, 2001. Cutaneous squamous-cell carcinoma. N Engl J Med, 344(13):975-983.

[4]AlvarezN, SevillaA, 2024. Current advances in photodynamic therapy (PDT) and the future potential of PDT-combinatorial cancer therapies. Int J Mol Sci, 25(2):1023.

[5]AnandS, HasanT, MaytinEV, 2024. Treatment of nonmelanoma skin cancer with pro-differentiation agents and photodynamic therapy: preclinical and clinical studies (Review). Photochem Photobiol, 100(6):1541-1560.

[6]AsgariMM, WangW, IoannidisNM, et al., 2016. Identification of susceptibility loci for cutaneous squamous cell carcinoma. J Invest Dermatol, 136(5):930-937.

[7]Baeza-HernándezG, CañuetoJ, 2023. Intralesional treatments for invasive cutaneous squamous cell carcinoma. Cancers (Basel), 16(1):158.

[8]BanderTS, NehalKS, LeeEH, 2019. Cutaneous squamous cell carcinoma: updates in staging and management. Dermatol Clin, 37(3):241-251.

[9]BhandariPR, PaiVV, 2014. Novel medical strategies combating nonmelanoma skin cancer. Indian J Dermatol, 59(6):531-546.

[10]BichakjianCK, OlenckiT, AasiSZ, et al., 2018. Merkel cell carcinoma, Version 1. 2018. NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 16(6):742-774.

[11]BorellaF, GallioN, MangheriniL, et al., 2023. Recent advances in treating female genital human papillomavirus related neoplasms with topical imiquimod. J Med Virol, 95(11):e29238.

[12]BrantschKD, MeisnerC, SchönfischB, et al., 2008. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol, 9(8):713-720.

[13]BurtonKA, AshackKA, KhachemouneA, 2016. Cutaneous squamous cell carcinoma: a review of high-risk and metastatic disease. Am J Clin Dermatol, 17(5):491-508.

[14]CasasA, 2020. Clinical uses of 5-aminolaevulinic acid in photodynamic treatment and photodetection of cancer: a review. Cancer Lett, 490:165-173.

[15]ChongCY, GohMS, PorcedduSV, et al., 2023. The current treatment landscape of cutaneous squamous cell carcinoma. Am J Clin Dermatol, 24(1):25-40.

[16]CivantosF, HelmenZM, BradleyPJ, et al., 2023. Lymph node metastases from non-melanoma skin cancer of the head and neck. Cancers (Basel), 15(17):4201.

[17]CohenDK, LeePK, 2016. Photodynamic therapy for non-melanoma skin cancers. Cancers (Basel), 8(10):90.

[18]DengBY, WangKP, ZhangLL, et al., 2023. Photodynamic therapy for inflammatory and cancerous diseases of the intestines: molecular mechanisms and prospects for application. Int J Biol Sci, 19(15):4793-4810.

[19]di NardoL, PellegriniC, di StefaniA, et al., 2020. Molecular genetics of cutaneous squamous cell carcinoma: perspective for treatment strategies. J Eur Acad Dermatol Venereol, 34(5):932-941.

[20]EggermontCJ, EggermontAMM, 2023. Shifting landscape in skin cancer incidence: the rising tide of cutaneous squamous cell carcinoma and potential implications for prevention. Br J Dermatol, 190(4):460-461.

[21]FarbergAS, MarsonJW, SoleymaniT, 2023. Advances in photodynamic therapy for the treatment of actinic keratosis and nonmelanoma skin cancer: a narrative review. Dermatol Ther (Heidelb), 13(3):689-716.

[22]FehrMK, HornungR, DegenA, et al., 2002. Photodynamic therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5-aminolevulinic acid. Lasers Surg Med, 30(4):273-279.

[23]FukuharaH, YamamotoS, KarashimaT, et al., 2021. Photodynamic diagnosis and therapy for urothelial carcinoma and prostate cancer: new imaging technology and therapy. Int J Clin Oncol, 26(1):18-25.

[24]HasanN, NadafA, ImranM, et al., 2023. Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches. Mol Cancer, 22:168.

[25]HufbauerM, CookeJ, van der HorstGT, et al., 2015. Human papillomavirus mediated inhibition of DNA damage sensing and repair drives skin carcinogenesis. Mol Cancer, 29(14):183.

[26]IoannidisNM, WangW, FurlotteNA, et al., 2018. Gene expression imputation identifies candidate genes and susceptibility loci associated with cutaneous squamous cell carcinoma. Nat Commun, 9:4264.

[27]KwiekB, SchwartzRA, 2016. Keratoacanthoma (KA): an update and review. J Am Acad Dermatol, 74(6):1220-1233.

[28]LiJ, ChenZD, BaiYX, et al., 2024. First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study. Nat Med, 30(3):740-748.

[29]LoveWE, BernhardJD, BordeauxJS, 2009. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review. Arch Dermatol, 145(12):1431-1438.

[30]MartinezJC, OtleyCC, 2001. The management of melanoma and nonmelanoma skin cancer: a review for the primary care physician. Mayo Clin Proc, 76(12):1253-1265.

[31]MortajaM, DemehriS, 2023. Skin cancer prevention ‒ recent advances and unmet challenges. Cancer Lett, 28(575):216406.

[32]MotaparthiK, KapilJP, VelazquezEF, 2017. Cutaneous squamous cell carcinoma: review of the eighth edition of the American Joint Committee on Cancer staging guidelines, prognostic factors, and histopathologic variants. Adv Anat Pathol, 24(4):171-194.

[33]NanzL, KeimU, KatalinicA, et al., 2024. Epidemiology of keratinocyte skin cancer with a focus on cutaneous squamous cell carcinoma. Cancers (Basel), 16(3):606.

[34]O'ConnellKA, OkhovatJP, ZeitouniNC, 2018. Photodynamic therapy for Bowen’s Disease (squamous cell carcinoma in situ) current review and update. Photodiagnosis Photodyn Ther, 24:109-114.

[35]PretiM, JouraE, Vieira-BaptistaP, et al., 2022. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus statements on pre-invasive vulvar lesions. J Low Genit Tract Dis, 26(3):229-244.

[36]QueSKT, ZwaldFO, SchmultsCD, 2018. Cutaneous squamous cell carcinoma: incidence, risk factors, diagnosis, and staging. J Am Acad Dermatol, 78(2):237-247.

[37]Rentroia-PachecoB, TokezS, BramerEM, et al., 2023. Personalised decision making to predict absolute metastatic risk in cutaneous squamous cell carcinoma: development and validation of a clinico-pathological model. eClinicalMedicine, 63:102150.

[38]RhodesLE, deRie MA, LeifsdottirR, et al., 2007. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Arch Dermatol, 143(9):1131-1136.

[39]SarinKY, LinY, DaneshjouR, et al., 2020. Genome-wide meta-analysis identifies eight new susceptibility loci for cutaneous squamous cell carcinoma. Nat Commun, 11:820.

[40]SchererD, KumarR, 2010. Genetics of pigmentation in skin cancer ‒ a review. Mutat Res, 705(2):141-153.

[41]SchmitzL, KanitakisJ, 2019. Histological classification of cutaneous squamous cell carcinomas with different severity. J Eur Acad Dermatol Venereol, 33(S8):11-15.

[42]SharpK, OlafsdottirEJ, SahniDR, et al., 2024. Survival of patients with basal cell carcinoma, squamous cell carcinoma, and squamous cell carcinoma in situ: a whole population study. J Am Acad Dermatol, 90(1):91-97.

[43]StătescuL, TrandafirLM, ȚarcăE, et al., 2023. Advancing cancer research: current knowledge on cutaneous neoplasia. Int J Mol Sci, 24(13):11176.

[44]ThompsonAK, KelleyBF, ProkopLJ, et al., 2016. Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis. JAMA Dermatol, 152(4):419-428.

[45]Verdaguer-FajaJ, TollA, BoadaA, et al., 2024. Management of cutaneous squamous cell carcinoma of the scalp: the role of imaging and therapeutic approaches. Cancers (Basel), 16(3):664.

[46]WelschMJ, TroianiBM, HaleL, et al., 2012. Basal cell carcinoma characteristics as predictors of depth of invasion. J Am Acad Dermatol, 67(1):47-53.

[47]WingeMCG, KellmanLN, GuoK, et al., 2023. Advances in cutaneous squamous cell carcinoma. Nat Rev Cancer, 23(7):430-449.

[48]WoodsGM, MalleyRC, MullerHK, 2005. The skin immune system and the challenge of tumour immunosurveillance. Eur J Dermatol, 15(2):63-69.

[49]XuM, MehlL, ZhangTW, et al., 2021. A UVB-responsive common variant at chromosome band 7p21.1 confers tanning response and melanoma risk via regulation of the aryl hydrocarbon receptor, AHR. Am J Hum Genet, 108(9):1611-1630.

[50]YamaguchiY, HataH, ImafukuK, et al., 2016. A case of erythroplasia of Queyrat successfully treated with combination carbon dioxide laser vaporization and surgery. J Eur Acad Dermatol Venereol, 30(3):497-498.

[51]ZhouC, JiangB, ZhangKY, et al., 2023. Clinical and histopathological characteristics, diagnosis and treatment, and comorbidities of Bowen’s disease: a retrospective study. Front Med (Lausanne), 15(10):1281540.